Metformin sensitizes endometrial cancer cells even progestin-resistant EC cells to progestin by promoting progesterone receptor (28), downregulating glyoxalase I expression (29), downregulating glyoxalase I expression (30). The gene discussed is PGR; the disease is endometrial cancer.